Seaport Therapeutics, Inc. (SPTX) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 13, 2026.
- Filings shown
- 17
- Open-market buys
- 3
- Open-market sells
- 0
- Buys, 10b5-1 box not checked
- 3 of 3
Counts cover the 17 most recent Form 4 filings Tradune holds for SPTX (filed May 4 – Nov 13, 2026); the score below covers only the trailing 90 days (1 buy, 0 sells). SEC EDGAR Form 4 filings for SPTX last checked Nov 21, 2026, 09:00 UTC; the latest SPTX filing Tradune holds was filed Nov 13, 2026. This is not guaranteed to be the complete record — see SPTX's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 2 filings Tradune holds for SPTX filed Nov 4 – Nov 13, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Denice TorresDirector | 1 | 0 | 5,000 | — | +$99,325 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
56/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at SPTX
Insiders reported 3 open-market purchases of SPTX between May 4, 2026 and Nov 13, 2026, across 3 distinct buyers. The most recent purchase was reported by Denice Torres (Director) on Nov 3, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Gift | 100,000 | — | 1,094,001 | −8.4% | Nov 10, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 5,000 | $19.87 | 5,000 | — | Nov 3, 2026 |
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 13,000 | $18.14 | 13,000 (indirect) | — | Jun 22, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 12,736,014 | — | 13,038,493 (indirect) | +4,211% | May 4, 2026 |
| Conversion of derivative Series B Preferred Stock | 3,031,578 | — | — | — | May 4, 2026 |
| Conversion of derivative | 965,255 | — | 16,685,013 (indirect) | +6.1% | May 4, 2026 |
| Conversion of derivative Series A-1 Preferred Stock | 40,000,000 | — | — | — | May 4, 2026 |
| Conversion of derivative | 2,681,265 | — | 15,719,758 (indirect) | +21% | May 4, 2026 |
| Conversion of derivative Series A-2 Preferred Stock | 8,421,052 | — | — | — | May 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 1,927,159 | — | 1,927,159 (indirect) | — | May 4, 2026 |
| Conversion of derivative | 804,379 | — | 2,731,538 (indirect) | +42% | May 4, 2026 |
| Conversion of derivative Series A-2 Preferred Stock | 6,052,631 | — | — | — | May 4, 2026 |
| Conversion of derivative Series B Preferred Stock | 2,526,315 | — | — | — | May 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 6,702 | — | 6,702 (indirect) | — | May 4, 2026 |
| Conversion of derivative Series B Preferred Stock | 21,052 | — | — | — | May 4, 2026 |
| Grant / award Stock Option (Right to Buy) | 63,680 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 33,515 | — | 33,515 | — | May 4, 2026 |
| Conversion of derivative Series B Preferred Stock | 105,263 | — | — | — | May 4, 2026 |
| Grant / award Stock Option (Right to Buy) | 63,680 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 3,351 | — | 3,351 | — | May 4, 2026 |
| Conversion of derivative Series B Preferred Stock | 10,526 | — | — | — | May 4, 2026 |
| Grant / award Stock Option (Right to Buy) | 63,680 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative Series B Preferred Stock | 42,105 | — | — | — | May 4, 2026 |
| Conversion of derivative | 13,406 | — | 13,406 (indirect) | — | May 4, 2026 |
| Grant / award Stock Option (Right to Buy) | 12,258 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative Series B Preferred Stock | 210,526 | — | — | — | May 4, 2026 |
| Conversion of derivative | 67,031 | — | 863,031 | +8.4% | May 4, 2026 |
| Grant / award Stock Option (Right to Buy) | 12,258 | — | — | — | Apr 30, 2026 |
| Grant / award Stock Option (Right to Buy) | 991,192 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 2,513,686 | — | 2,513,686 (indirect) | — | May 4, 2026 |
| Conversion of derivative | 2,681,265 | — | 5,194,951 (indirect) | +107% | May 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 1,100,000 | $18.00 | 6,294,951 (indirect) | +21% | May 4, 2026 |
| Conversion of derivative Series A-2 Preferred Stock | 2,513,686 | — | — | — | May 4, 2026 |
| Conversion of derivative Series B Preferred Stock | 2,681,265 | — | — | — | May 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 20,109 | — | 20,109 | — | May 4, 2026 |
| Conversion of derivative Series B Preferred Stock | 63,157 | — | — | — | May 4, 2026 |
| Grant / award Stock Option (Right to Buy) | 63,680 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 271,813 | — | — | — | Apr 30, 2026 |
| Grant / award Stock Option (Right to Buy) | 1,486,786 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 12,258 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 12,258 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 12,258 | — | — | — | Apr 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 49,033 | — | — | — | Apr 30, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to SPTX's (Nov 13, 2026).
Frequently asked about SPTX insider activity
How many insiders bought SPTX stock in these Form 4 filings?
3 distinct insiders at Seaport Therapeutics, Inc. reported 3 open-market purchases (Form 4 code P) of SPTX shares between May 4, 2026 and Nov 13, 2026, the most recent filed by Denice Torres (Director) on Nov 3, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for SPTX?
The most recent Form 4 on this page was filed by Daphne Zohar (Chief Executive Officer) on Nov 13, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market SPTX insider purchase shown?
The largest open-market purchase among the filings shown was 1,100,000 SPTX shares at $18.00 (about $19,800,000) by Arch Venture Partners Xii, LLC (10% owner) on May 4, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent SPTX insider purchases have the Form 4 10b5-1 box checked?
No. All 3 SPTX open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Denice Torres (Director) on Nov 3, 2026, 5,000 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for SPTX — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.